Trial Profile
A Randomized-Withdrawal Phase 3 Study Evaluation the Safety and Efficacy of Oral Nalfurafine HCl (AC-820)in Subjects on Hemodialysis With Uremic Pruritus (Renal Itch)
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Nalfurafine (Primary)
- Indications Pruritus
- Focus Registrational; Therapeutic Use
- Sponsors Acologix
- 17 Jun 2014 New trial record